Mapping large numbers of results may take a few moments.
Search Results
Showing 101 - 150 of 268 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company FLAG Therapeutics Inc. | Activity: Research and Development | Company Description FLAG Therapeutics develops cancer therapeutics using new classes of small molecules which have selective dual activity: antiangiogenesis and chemotherapeutic. | Location Raleigh | |
Company FUJIFILM Diosynth Biotechnologies USA Inc. (Morrisville) | Activity: Production and Manufacturing | Company Description FUJIFILM Diosynth Biotechnologies is a contract development and manufacturing organization for biologics, vaccines, cell and gene therapies, and oncolytic viruses. Services include cell line development, process and analytical development, clinical and commercial manufacturing and bioprocess research and development. | Location Morrisville | |
Company G1 Therapeutics Inc. | Activity: Research and Development | Company Description G1 Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for those affected by cancer. | Location Research Triangle Park | |
Company Gateway Bio Inc. | Activity: Research and Development | Company Description Gateway Bio is developing a rapid onset anticoagulant. | Location Durham | |
Company Genebiology Inc. | Activity: Research and Development | Company Description GeneBiology identifies, patents and develops new parenteral formulations of approved drugs for unmet medical needs using the 505b2 regulatory pathway. | Location Research Triangle Park | |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham | |
Company Generys Biopharmaceuticals Corp. | Activity: Research and Development | Company Description Generys BioPharmaceuticals develops drugs, formulations and generics for unmet medical needs. Generys also offers therapeutic pipeline portfolio consulting and management services on a contract basis. | Location Chapel Hill | |
Company GeneVentiv Therapeutics Inc. | Activity: Research and Development | Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. | Location Raleigh | |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill | |
Company Glycomine Inc. | Activity: Research and Development | Company Description Glycomine is developing orphan drugs for serious rare disorders of metabolism and protein misfolding. | Location Chapel Hill | |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park | |
Company Grid Therapeutics LLC | Activity: Research and Development | Company Description Grid Therapeutics is developing cancer therapeutics that utilize a unique platform that develops human-derived antibodies for the treatment of multiple cancer types. | Location Durham | |
Company Grifols (Clayton) | Activity: Production and Manufacturing | Company Description Grifols' manufacturing campus in Clayton produces plasma-derived medicines and other biopharmaceutical solutions that treat patients with chronic, rare and, at times, life-threatening conditions. | Location Clayton | |
Company Grifols (RTP) | Activity: Sales and Operations | Company Description Grifols manufactures and markets plasma-derived medicines and other biopharmaceutical solutions to treat chronic, rare, and, at times, life-threatening conditions in the therapeutic areas of immunology, pulmonology, hematology, thrombolytics and neurology. | Location Research Triangle Park | |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham | |
Company GSK (Zebulon) | Activity: Production and Manufacturing | Company Description GlaxoSmithKline manufactures solid-dose products, including tablets and capsules, at its Zebulon facility. The plant also does granulation, drying and packaging, and contract manufacturing of antibiotics for other companies. | Location Zebulon | |
Company Helixomer Inc. | Activity: Research and Development | Company Description Helixomer is developing RNA-based anticoagulants. | Location Raleigh | |
Company HIPRA Scientific USA LLC | Activity: Research and Development | Company Description Hipra researches and develops vaccines, diagnostics and pharmaceuticals for animal health. | Location Raleigh | |
Company Hudson Therapeutics Inc. | Activity: Research and Development | Company Description Hudson Therapeutics, a subsidiary of Shaperon Inc., conducts global clinical trials and business development for anti-inflammatory and immunology drugs. | Location Research Triangle Park | |
Company Humacyte Inc. | Activity: Research and Development | Company Description Humacyte develops a technology platform that isolates and grows stable investigational human tissue replacements with potential regenerative medicine, vascular and nonvascular surgery applications. | Location Durham | |
Company Immorna Biotherapeutics Inc. | Activity: Research and Development | Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. | Location Raleigh | |
Company Immunovant Inc. | Activity: Research and Development | Company Description Immunovant is a clinical-stage biopharmaceutical company developing treatments for autoimmune diseases. | Location Durham | |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park | |
Company Imugene Limited (Durham) | Activity: Research and Development | Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. | Location Durham | |
Company Inceptor Bio LLC | Activity: Research and Development | Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. | Location Raleigh | |
Company Incyclix Bio LLC | Activity: Research and Development | Company Description Incyclix Bio is developing novel cancer treatments through the selective inhibition of specific CDK (cyclin-dependent kinase) family members to address unmet medical needs of oncology patients. | Location Research Triangle Park | |
Company Inhalon Biopharma Inc. | Activity: Research and Development | Company Description Inhalon Biopharma is a clinical-stage, inhaled immunotherapy company developing prophylactic and therapeutic antibodies (mAb) for acute respiratory infections. Inhalon has a patented proprietary muco-trapped mAb platform technology with broad IP coverage of inhaled mAb delivery. | Location Morrisville | |
Company Insoma Bio Inc. | Activity: Research and Development | Company Description InSomaBio is developing recombinant, protein-based materials to solve problems in tissue engineering and regenerative medicine. | Location Durham | |
Company Invitrox Inc. | Activity: Contract Research and Testing | Company Description Invitrox provides GLP-compliant bioanalytical services for nonclinical and clinical drug development studies, with expertise in method development and validation, small and large molecules, sample analysis, metabolites, biomarkers and drug monitoring. | Location Research Triangle Park | |
Company Irex Pharma LLC | Activity: Research and Development | Company Description Irex Pharma is an early-stage drug discovery company focused on identifying and commercializing novel therapeutics to control excess mucus in pulmonary patients. | Location Chapel Hill | |
Company Ironshore Pharmaceuticals Inc. | Activity: Sales and Operations | Company Description Ironshore Pharmaceuticals develops, commercializes and distributes novel pharmaceuticals, including a novel oral treatment for ADHD with delayed-release properties. | Location Morrisville | |
Company Istari Oncology Inc. | Activity: Research and Development | Company Description ISTARI Oncology is developing immunotherapies for cancer treatment. | Location Morrisville | |
Company Jaguar Gene Therapy LLC (Analytical Development) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. | Location Durham | |
Company Jaguar Gene Therapy LLC (Process Sciences Lab) | Activity: Research and Development | Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's process sciences lab is located in Cary. | Location Cary | |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham | |
Company Jurata Thin Film Inc. | Activity: Research and Development | Company Description Jurata Thin Film is developing an oral, thin film vaccine delivery method that preserves live viruses, bacteria, antibodies and enzymes inexpensively, without refrigeration. | Location Chapel Hill | |
Company Kaio Therapy LLC | Activity: Research and Development | Company Description KAIO Therapy develops an immunotherapy technology to treat solid tumors. | Location Raleigh | |
Company Karamedica Inc. | Activity: Research and Development | Company Description Karamedica has developed a plasma treatment of batch quantities of chitosan and other biopolymers in order to lower endotoxin levels. Karamedica is also currently developing a nanoparticle therapy for cerebral amyloid angiopathy. | Location Raleigh | |
Company KBI Biopharma Inc. (Corporate HQ) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. | Location Durham | |
Company KBI Biopharma Inc. (Patriot Park Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services such as formulation, analytical method development, stability services, process development and recombinant protein API manufacturing. The Patriot Park Facility is a 150,000 square-foot cGMP biologics manufacturing facility. | Location Durham | |
Company KBI Biopharma Inc. (Venture Center Facility) | Activity: Production and Manufacturing | Company Description KBI Biopharma, a JSR Life Sciences Company, offers contract development and biopharmaceutical manufacturing services. KBI's Venture Center Facility conducts process and analytical development, process characterization and cell line development. | Location Durham | |
Company Kincell Bio | Activity: Production and Manufacturing | Company Description Kincell Bio is a contract development and manufacturing organization that offers analytical development, process development, CMC consulting and early stage GMP cell therapy manufacturing. | Location Research Triangle Park | |
Company Kowa Research Institute Inc. | Activity: Research and Development | Company Description Kowa Research Institute, a division of Kowa Company Ltd., develops therapeutic drugs for the treatment of cardio-metabolic diseases such as diabetes and atherosclerosis, pain and sensory organ disorders. | Location Morrisville | |
Company Krenitsky Pharmaceuticals Inc. | Activity: Research and Development | Company Description Krenitsky Pharmaceuticals discovers and develops drug candidates, with a focus on disorders of the nervous system. | Location Chapel Hill | |
Company KriGen Pharmaceuticals LLC | Activity: Production and Manufacturing | Company Description KriGen Pharmaceuticals develops pharmaceutical products, and provides finished product formulation solutions and sterile active pharmaceutical ingredients to generic and branded pharmaceutical companies. | Location Lillington | |
Company Kriya Therapeutics Inc. | Activity: Production and Manufacturing | Company Description Kriya Therapeutics develops AAV-based gene therapies for the treatment of type 1 and type 2 diabetes, severe obesity, thyroid eye disease (TED) and other indications. This location is the company's internal manufacturing facility. | Location Morrisville | |
Company LadeRx LLC | Activity: Research and Development | Company Description LadeRx is developing new technology for diagnostic radiology. | Location Durham | |
Company Lamassu Pharma Inc. | Activity: Research and Development | Company Description Lamassu Pharma is developing small molecule therapeutics to treat acute pancreatitis. | Location Durham | |
Company Life Edit Therapeutics | Activity: Research and Development | Company Description Life Edit Therapeutics, an ElevateBio company, identifies novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships. | Location Durham | |
Company LifeNet Health | Activity: Research and Development | Company Description LifeNet Health provides transplant solutions, including cellular therapy research, organ procurement and bio-implant. The North Carolina facility isolates liver cells and adult stem cells for applications in drug discovery and toxicity testing. | Location Research Triangle Park |